There are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetMino-Lokpotentialmarket>$1BOnly biotechwith 2 Myron'son theleadershipteamWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mWe will openupinternationalsites forMino-Lok trialI'm ashareholdermyselfNot manycompaniesthis size with2 late stageassetsWe willhaveexclusivityAn actualiMSCupdateWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Insidersinvested$26.5mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I/ONTAKis our leadassetI/ONTAKwas thebest deal Iever madeOur Halo-Lido trial willhave finalpatient byend of 2022We expect tofinish theMino-Loktrial this yearMyron Holubiakand I founded aprivatecompany in2013Hemorrhoidsis a $2BmarketWe had aphase 2btrial with100%efficacyI won't diluteshareholdersMino-WrapThere are noFDAapproveddrugs to treathemorrhoidsMino-Lokis our leadassetMino-Lokpotentialmarket>$1BOnly biotechwith 2 Myron'son theleadershipteamWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mWe will openupinternationalsites forMino-Lok trialI'm ashareholdermyselfNot manycompaniesthis size with2 late stageassetsWe willhaveexclusivityAn actualiMSCupdateWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Insidersinvested$26.5mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.I/ONTAKis our leadassetI/ONTAKwas thebest deal Iever madeOur Halo-Lido trial willhave finalpatient byend of 2022We expect tofinish theMino-Loktrial this yearMyron Holubiakand I founded aprivatecompany in2013Hemorrhoidsis a $2BmarketWe had aphase 2btrial with100%efficacyI won't diluteshareholdersMino-Wrap

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. There are no FDA approved drugs to treat hemorrhoids
  2. Mino-Lok is our lead asset
  3. Mino-Lok potential market >$1B
  4. Only biotech with 2 Myron's on the leadership team
  5. We have enough cash to go well into 2023
  6. I/ONTAK's potential market is >$300m
  7. We will open up international sites for Mino-Lok trial
  8. I'm a shareholder myself
  9. Not many companies this size with 2 late stage assets
  10. We will have exclusivity
  11. An actual iMSC update
  12. We intend to submit a BLA in 2H 2022
  13. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  14. Insiders invested $26.5m
  15. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  16. I/ONTAK is our lead asset
  17. I/ONTAK was the best deal I ever made
  18. Our Halo-Lido trial will have final patient by end of 2022
  19. We expect to finish the Mino-Lok trial this year
  20. Myron Holubiak and I founded a private company in 2013
  21. Hemorrhoids is a $2B market
  22. We had a phase 2b trial with 100% efficacy
  23. I won't dilute shareholders
  24. Mino-Wrap